739 related articles for article (PubMed ID: 25759553)
1. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis.
Yang JJ; Hu ZG; Shi WX; Deng T; He SQ; Yuan SG
World J Gastroenterol; 2015 Mar; 21(9):2807-15. PubMed ID: 25759553
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: A meta-analysis containing 8252 patients.
Zhou Y; Wei Q; Fan J; Cheng S; Ding W; Hua Z
Clin Chim Acta; 2018 Apr; 479():181-189. PubMed ID: 29407690
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis.
Cheng H; Long F; Jaiswar M; Yang L; Wang C; Zhou Z
Sci Rep; 2015 Jul; 5():11026. PubMed ID: 26226887
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.
Yu Y; Wang H; Yan A; Wang H; Li X; Liu J; Li W
BMC Cancer; 2018 Apr; 18(1):383. PubMed ID: 29618336
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies.
Mei Z; Shi L; Wang B; Yang J; Xiao Z; Du P; Wang Q; Yang W
Cancer Treat Rev; 2017 Jul; 58():1-13. PubMed ID: 28602879
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of neutrophil to lymphocyte ratio in patients with gastrointestinal stromal tumors: A meta-analysis.
Luo XF; Zhou LH
Clin Chim Acta; 2018 Feb; 477():7-12. PubMed ID: 29175648
[TBL] [Abstract][Full Text] [Related]
7. Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis.
Sun J; Chen X; Gao P; Song Y; Huang X; Yang Y; Zhao J; Ma B; Gao X; Wang Z
Dis Markers; 2016; 2016():7862469. PubMed ID: 26924872
[TBL] [Abstract][Full Text] [Related]
8. Validation of the pretreatment neutrophil-lymphocyte ratio as a predictor of overall survival in a cohort of patients with pancreatic ductal adenocarcinoma.
Ben Q; An W; Wang L; Wang W; Yu L; Yuan Y
Pancreas; 2015 Apr; 44(3):471-7. PubMed ID: 25423560
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of neutrophil-to-lymphocyte ratio in breast cancer.
Chen J; Deng Q; Pan Y; He B; Ying H; Sun H; Liu X; Wang S
FEBS Open Bio; 2015; 5():502-7. PubMed ID: 26137435
[TBL] [Abstract][Full Text] [Related]
10. The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients.
Cheng H; Luo G; Lu Y; Jin K; Guo M; Xu J; Long J; Liu L; Yu X; Liu C
Pancreatology; 2016; 16(6):1080-1084. PubMed ID: 27665172
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment blood neutrophil/lymphocyte ratio is associated with metastasis and predicts survival in patients with pancreatic cancer.
Guo J; Wu M; Guo L; Zuo Q
Bull Cancer; 2018 Feb; 105(2):146-154. PubMed ID: 29290332
[TBL] [Abstract][Full Text] [Related]
12. The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: A meta-analysis.
Lu Y; Jiang J; Ren C
PLoS One; 2020; 15(4):e0230979. PubMed ID: 32241019
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of the utility of the neutrophil-to-lymphocyte ratio in predicting survival after pancreatic cancer resection.
Mowbray NG; Griffith D; Hammoda M; Shingler G; Kambal A; Al-Sarireh B
HPB (Oxford); 2018 May; 20(5):379-384. PubMed ID: 29336893
[TBL] [Abstract][Full Text] [Related]
14. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival of epithelial ovarian cancer: a systematic review and meta-analysis of observational studies.
Yang Z; Gu JH; Guo CS; Li XH; Yang WC
Oncotarget; 2017 Jul; 8(28):46414-46424. PubMed ID: 28423365
[TBL] [Abstract][Full Text] [Related]
15. Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma.
Abe T; Amano H; Kobayashi T; Hanada K; Nakahara M; Ohdan H; Noriyuki T
Eur J Surg Oncol; 2018 Oct; 44(10):1573-1579. PubMed ID: 29807728
[TBL] [Abstract][Full Text] [Related]
16. Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer.
Sierzega M; Lenart M; Rutkowska M; Surman M; Mytar B; Matyja A; Siedlar M; Kulig J
Ann Surg Oncol; 2017 Mar; 24(3):808-815. PubMed ID: 27770341
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma: A meta-analysis.
Wang J; Zhou X; Liu Y; Li Z; Li X
PLoS One; 2017; 12(4):e0176008. PubMed ID: 28441396
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of neutrophil to lymphocyte ratio in patients with gallbladder carcinoma.
Zhang L; Wang R; Chen W; Xu X; Dong S; Fan H; Liu C
HPB (Oxford); 2016 Jul; 18(7):600-7. PubMed ID: 27346141
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer.
Asaoka T; Miyamoto A; Maeda S; Tsujie M; Hama N; Yamamoto K; Miyake M; Haraguchi N; Nishikawa K; Hirao M; Ikeda M; Sekimoto M; Nakamori S
Pancreatology; 2016; 16(3):434-40. PubMed ID: 26852169
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic review.
Stevens L; Pathak S; Nunes QM; Pandanaboyana S; Macutkiewicz C; Smart N; Smith AM
HPB (Oxford); 2015 Apr; 17(4):285-91. PubMed ID: 25431369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]